Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 1, 1999, Pages 413-422

  Caraco, Yoseph ^a,b   Sheller, James ^b   Wood, Alastair J J ^b,c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; CYTOCHROME P450 ISOENZYME; DEBRISOQUINE; QUINIDINE;

ARTICLE; CAUCASIAN; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMETHYLATION; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG METABOLISM; DRUG STRUCTURE; ETHNOLOGY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALGESICS, OPIOID; ASIAN CONTINENTAL ANCESTRY GROUP; BIOTRANSFORMATION; CODEINE; CROSS-OVER STUDIES; DEALKYLATION; DEBRISOQUIN; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ENZYME INHIBITORS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MORPHINE; PSYCHOMOTOR PERFORMANCE; PUPIL; QUINIDINE; RESPIRATORY MECHANICS;

EID: 0033046088     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alvan G, Bechtel P, Iselius L and Gundert-Ramy U (1990) Hydroxylation polymorphism of debrisoquine and mephenytoin in European populations. Eur J Clin Pharmacol 39:533-537.
2. 3H]codeine phosphate in man and in the dog. Arzneim-Forsch 28:308-311.
3. Bertilsson L, Lou YQ, Du YL, Liu Y, Kuang TY, Liao XM, Wang KY, Reviriego J, Iselius L and Sjoqvist F (1992) Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin. Clin Pharmacol Ther 51:388-397.
4. Brosen K (1990) Recent developments in hepatic drug oxidation. Implication for clinical pharmacokinetics. Clin Pharmacokinet 18:220-239.
5. Caraco Y, Sheller JR and Wood AJJ (1996a) Pharmacogenetic determinants of the effects of codeine and prediction of drug interactions. J Pharmacol Exp Ther 278:1165-1174.
6. Caraco Y, Tateishi T and Wood AJJ (1995) Interethnic difference in omeprazole's inhibition of diazepam metabolism. Clin Pharmacol Ther 58:62-72.
7. Caraco Y, Wilkinson GR and Wood AJJ (1996b) Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6 and 3A by omeprazole. Clin Pharmacol Ther 60:396-404.
8. Chen ZR, Irvine RJ, Somogyi AA and Bochner F (1991) Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 48:2165-2171.
9. Desmeules J, Gascon MP, Dayer P and Magistris M (1991) Impact of environmental and genetic factors on codeine analgesia. Eur J Clin Pharmacol 41:23-26.
10. Eggen AE and Andrew M (1994) Use of codeine analgesics in a general population. A Norwegian study of moderately strong analgesics. Eur J Clin Pharmacol 46: 491-496.
11. Fraser HF, Nash TL, Vanhorn GD and Isbell H (1954) Use of miotic effect in evaluating analgesic drugs in man. Arch Int Pharmacodyn 98:443-451.
12. Heiskanen T, Olkkola KT and Kalso E (1998) Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacol Ther 64:603-611.
13. Horai Y, Nakano M, Ishizaki T, Ishikawa K, Zhou HH, Zhou BJ, Liao CL and Zhang LM (1989) Metoprolol and mephenytoin oxidation polymorphism in far east oriental subjects: Japanese versus mainland Chinese. Clin Pharmacol Ther 46:198-207.
14. Kallow W (1991) Interethnic variation of drug metabolism. Trends Pharmacol Sci 121:102-107.
15. Mortimer O, Persson K, Ladona MG, Spalding D, Zanger UM, Meyer UA and Rane A (1990) Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: Relationship to the presence of immune identified cytochrome P-450IID1. Clin Pharmacol Ther 47:27-35.
16. Otton SV, Schadel M, Cheung SW, Kaplan HL, Busto UE and Sellers EM (1993b) CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone. Clin Pharmacol Ther 54:463-472.
17. Otton SV, Wu D, Joffe RT, Cheung SW and Sellers EM (1993a) Inhibition by fluoxetine of cytochrome P450 2D6 activity. Clin Pharmacol Ther 53:401-409.
18. Read DJC (1967) A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med 1:20-32.
19. Seed JC, Wallenstein SL, Houde RW and Bellville JW (1958) A comparison of the analgesic and respiratory effects of dihydrocodeine and morphine in man. Arch Int Pharmacodyn CXVI:293-339.
20. Sindrop SH, Brosen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo HR and Gram LF (1991) Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharmacol Ther 49:686-693.
21. Snafilippo G (1948) Contributo sperimentale all' ipostesi della smetilazione della codeine nell' organismo. I. Inflenze della dose sull' assuefazione alla codeine. II. Assuefazione alla codeine attenuta con somministrazione di morfina. Boll Soc Ital Biol Sper 24:723-726.
22. Tseng CY, Wang SL, Lai MD, Lai ML and Huang JD (1996) Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes. Clin Pharmacol Ther 60:177-182.
23. Wechsler D (1981) A Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York.
24. Wood AJJ and Zhou HH (1991) Ethnic differences in drug disposition and responsiveness. Clin Pharmacokinet 20:350-373.
25. Yue QY, Hasselstrom J, Svensson JO and Sawe J (1991a) Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: Comparison between extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol 31:635-642.
26. Yue QY, Svensson JO, Alm C, Sjoqvist F and Sawe J (1989a) Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br J Clin Pharmacol 28:639-645.
27. Yue QY, Svensson JO, Alm C, Sjoqvist F and Sawe J (1989b) Interindividual and interethnic differences in the demethylation and glucuronidation of codeine. Br J Clin Pharmacol 28:629-637.
28. Yue QY, Svensson JO, Sjoqvist F and Sawe J (1991b) A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasians extensive hydroxylators of debrisoquine. Br J Clin Pharmacol 31:643-647.
29. Zhang Y, Reviriego J, Lou YQ, Sjoqvist F and Bertilsson L (1990) Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: Interethnic differences in comparison with White subjects. Clin Pharmacol Ther 48:496-502.
30. Zhou HH, Sheller JR, Nu H, Wood M and Wood AJJ (1993) Ethnic differences in response to morphine. Clin Pharmacol Ther 54:507-513.